 SAN DIEGO-- BUSINESS WIRE --QuidelOrtho Corporation Nasdaq: QDEL QuidelOrtho, a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that members of its management team are scheduled to participate in the 41st Annual J.P. Morgan Healthcare Conference in San Francisco beginning on January 9, 2023, with a presentation scheduled for 9:00 a.m. PST 12:00 p.m. EST. 